William Weidner, MD
Obstetrics & Gynecology · Elkhorn, NENPI 1881705234
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations.
Across 84 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$527
- Astellas Pharma US Inc$218
- Pacira Pharmaceuticals Incorporated$138
- Bayer$126
- Astellas Pharma Global Development$122
- Hologic Sales And Service, LLC$115
- plus $956 from 23 others
What the payments were for
- Food & beverage$2,15798%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $527 |
| Astellas Pharma US Inc | 6 | $218 |
| Pacira Pharmaceuticals Incorporated | 2 | $138 |
| Bayer | 6 | $126 |
| Astellas Pharma Global Development | 1 | $122 |
| Hologic Sales And Service, LLC | 2 | $115 |
| Mayne Pharma Commercial LLC | 7 | $110 |
| Exeltis, USA Inc. | 4 | $86 |
| Coopersurgical, Inc. | 1 | $79 |
| Organon | 3 | $61 |
| Therapeuticsmd, Inc. | 4 | $57 |
| Daiichi Sankyo Inc. | 4 | $57 |
| Myovant Sciences Inc. | 3 | $53 |
| Johnson & Johnson | 2 | $53 |
| AMAG Pharmaceuticals, Inc. | 3 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 3 | $41 |
| Pfizer | 3 | $37 |
| Mallinckrodt Enterprises LLC | 2 | $34 |
| Medtronic | 1 | $29 |
| Merck | 2 | $25 |
| Conmed Corporation | 1 | $23 |
| KARL Storz Endoscopy-america | 1 | $22 |
| Asensus Surgical, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Roche Diagnostics Corporation | 1 | $16 |
| Gynesonics, Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$242
- Orilissa$125
- EXPAREL$125
- ACESSA PROVU SYSTEM$111
- ORIAHNN$104
How this compares
$2,202 in reported general payments places this provider in the 75th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $1,669 |
| Clobetasol Propionate | 15 | $816 |
| Raloxifene Hcl | 16 | $489 |
| Levothyroxine Sodium | 22 | $141 |
| Atorvastatin Calcium | 18 | $98 |
| Fluconazole | 12 | $73 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Elkhorn
- Jessica BrackenElkhorn$8K
- Carolee JonesElkhorn$4K
- Judith ScottElkhorn$3K
- Allison PhillipsElkhorn$2K
- John CoteOmaha$236K
- Gregory HeidrickLincoln$80K
- Robin ClemmerOmaha$19K
- Angela GroneBeatrice$17K
- Chandra LjunggrenLincoln$13K
- Emily NeriLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.